Case Report
Interstitial lung disease due to anti-TNF use in the treatment of psoriasis
Débora Dorneles Cunha de Queiroz Turíbio
, Francisco Clitson Sousa Oliveira, Sandra Maria Fonseca Barreto, Thaís Barros Felippe Jabour
Corresponding author
Department of Medicine, Hospital Universitário Onofre Lopes, Natal, RN, Brazil
Read
6255
Timeswas read the article
2658
Total PDF
3597
Total HTML
Share statistics
array:24 [ "pii" => "S0365059621001045" "issn" => "03650596" "doi" => "10.1016/j.abd.2020.08.016" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "364" "copyright" => "Sociedade Brasileira de Dermatologia" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by/4.0/" "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "pt" => array:19 [ "pii" => "S2666275221001053" "issn" => "26662752" "doi" => "10.1016/j.abdp.2020.08.015" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "364" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by/4.0/" "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "pt" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Caso Clínico</span>" "titulo" => "Doença pulmonar intersticial pelo uso de anti‐TNF no tratamento da psoríase" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => "pt" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "447" "paginaFinal" => "450" ] ] "contieneResumen" => array:1 [ "pt" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2005 "Ancho" => 2006 "Tamanyo" => 489652 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Opacidades retículo‐nodulares esparsas no parênquima pulmonar bilateralmente, mais evidente nos campos pulmonares inferiores. Em relação ao exame anterior, houve resolução parcial das opacidades.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Débora Dorneles Cunha de Queiroz Turíbio, Francisco Clitson Sousa Oliveira, Sandra Maria Fonseca Barreto, Thaís Barros Felippe Jabour" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Débora Dorneles Cunha de Queiroz" "apellidos" => "Turíbio" ] 1 => array:2 [ "nombre" => "Francisco Clitson Sousa" "apellidos" => "Oliveira" ] 2 => array:2 [ "nombre" => "Sandra Maria Fonseca" "apellidos" => "Barreto" ] 3 => array:2 [ "nombre" => "Thaís Barros Felippe" "apellidos" => "Jabour" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0365059621001045" "doi" => "10.1016/j.abd.2020.08.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001045?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001053?idApp=UINPBA00008Z" "url" => "/26662752/0000009600000004/v1_202107170646/S2666275221001053/v1_202107170646/pt/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0365059621001094" "issn" => "03650596" "doi" => "10.1016/j.abd.2020.07.014" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "369" "copyright" => "Sociedade Brasileira de Dermatologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by/4.0/" "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Recurrence of melanoma in the scar after excised Spitz nevus in a 17-year-old child" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "451" "paginaFinal" => "453" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1353 "Ancho" => 905 "Tamanyo" => 329163 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Histopathological image of the melanoma. Caption: Nodular melanoma, epithelioid type, Clark 3, Breslow 2.39-mm. (A), Hematoxylin & eosin ×40, (B), Hematoxylin & eosin ×100. The arrows indicate the pathological mitoses in the tumor.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Joanna Pogorzelska-Dyrbuś, Beata Bergler-Czop, Maciej Kajor" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Joanna" "apellidos" => "Pogorzelska-Dyrbuś" ] 1 => array:2 [ "nombre" => "Beata" "apellidos" => "Bergler-Czop" ] 2 => array:2 [ "nombre" => "Maciej" "apellidos" => "Kajor" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2666275221001107" "doi" => "10.1016/j.abdp.2020.07.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001107?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001094?idApp=UINPBA00008Z" "url" => "/03650596/0000009600000004/v4_202107160617/S0365059621001094/v4_202107160617/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0365059621001033" "issn" => "03650596" "doi" => "10.1016/j.abd.2020.06.025" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "363" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by/4.0/" "subdocumento" => "crp" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Blastoid mantle cell lymphoma: cutaneous infiltration" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "442" "paginaFinal" => "446" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0030" "etiqueta" => "Figure 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 843 "Ancho" => 3333 "Tamanyo" => 798233 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0030" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Cutaneous mantle-cell lymphoma. Immunohistochemistry staining: (A) CD20, (B) Cyclin-D1 and (C) PAX5.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mariana Righetto de Ré, Flávia de Oliveira Valentim, Mariangela Esther Alencar Marques, Silvio Alencar Marques" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Mariana Righetto" "apellidos" => "de Ré" ] 1 => array:2 [ "nombre" => "Flávia de Oliveira" "apellidos" => "Valentim" ] 2 => array:2 [ "nombre" => "Mariangela Esther Alencar" "apellidos" => "Marques" ] 3 => array:2 [ "nombre" => "Silvio Alencar" "apellidos" => "Marques" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2666275221001041" "doi" => "10.1016/j.abdp.2020.06.026" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001041?idApp=UINPBA00008Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001033?idApp=UINPBA00008Z" "url" => "/03650596/0000009600000004/v4_202107160617/S0365059621001033/v4_202107160617/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Interstitial lung disease due to anti-TNF use in the treatment of psoriasis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "447" "paginaFinal" => "450" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Débora Dorneles Cunha de Queiroz Turíbio, Francisco Clitson Sousa Oliveira, Sandra Maria Fonseca Barreto, Thaís Barros Felippe Jabour" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Débora Dorneles Cunha de Queiroz" "apellidos" => "Turíbio" "email" => array:1 [ 0 => "deboradorneles4@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Francisco Clitson Sousa" "apellidos" => "Oliveira" ] 2 => array:2 [ "nombre" => "Sandra Maria Fonseca" "apellidos" => "Barreto" ] 3 => array:2 [ "nombre" => "Thaís Barros Felippe" "apellidos" => "Jabour" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Medicine, Hospital Universitário Onofre Lopes, Natal, RN, Brazil" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3239 "Ancho" => 3333 "Tamanyo" => 988133 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bilateral pulmonary infiltration characterized by ground-glass opacities and fine reticulation with a basal predominance. Nodular and ground-glass opacities with sparse centrilobular distribution, more evident in the middle lobe.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Psoriasis is characterized by the World Health Organization (WHO) as a systemic, non-contagious, inflammatory, and incapacitating disease, for which there is no cure. Systemic treatment is required in 20% to 30% of patients.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Being highly stigmatizing, the impact of psoriasis extends far beyond the body surface, affecting the individuals’ social relationships and personality.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">One of the main focal points of psoriasis research has been the development of biological therapies for this disease. Adalimumab is the first anti-human tumor necrosis factor (TNF) monoclonal antibody fully developed for the treatment of psoriasis and other immune-mediated diseases.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> However, varying adverse effects have been identified in patients treated with biological agents.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Recently, cases have been reported associating the use of TNF-alpha inhibitors infliximab and etanercept to interstitial lung disease.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> However, the literature is scarce regarding the correlation between the use of adalimumab for the treatment of psoriasis and the subsequent development of interstitial pneumonia and this motivated the present report.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Case report</span><p id="par0015" class="elsevierStylePara elsevierViewall">A 58-year-old patient, had been undergoing dermatological follow-up for plaque psoriasis for ten years. The patient had been well controlled during the last 5 years with the use of adalimumab (Humira™), receiving a dose of 40 mg every 14 days. Chest X-ray and PPD test were performed for annual screening due to the use of an immunobiological agent. Parietal thickening was observed in the posterior basal segments of the lung on the chest radiography, which prompted the case investigation.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The patient was asymptomatic from the respiratory point of view. On physical examination, there were rales in the pulmonary bases, bilaterally, without any other alterations. A chest computed tomography (CT) was performed (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>), with the following results: bilateral pulmonary infiltrate characterized by ground-glass opacities and a thin reticulation with basal predominance. Nodular and ground-glass opacities with sparse lobular center distribution were observed, which were more evident in the middle lobe.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Adalimumab was discontinued due to the hypothesis of drug-induced pulmonary tuberculosis or interstitial pneumopathy. The patient denied having had contact with individuals with respiratory symptoms. A bronchoscopy was performed with bronchial lavage and culture, bacterioscopy, fungoscopy and AFB testing, which were all negative. Then, the hypothesis of infectious etiology was ruled out and a new chest CT was requested (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>) three months after the medication was discontinued, which showed sparse reticulonodular opacities in the lung parenchyma bilaterally, more evident in the lower lung fields, with partial resolution in comparison to the previous CT.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Due to the significant reduction in pulmonary infiltration after adalimumab discontinuation and without any other additional therapy, the dermatologists and the pulmonologist concluded that the causal relationship was sufficient for the diagnosis. One year after adalimumab discontinuation, the patient is using ustekinumab.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Discussion</span><p id="par0035" class="elsevierStylePara elsevierViewall">The use of tumor necrosis factor (TNF) inhibitors in chronic inflammatory diseases has been well reported, showing that they are safe drugs, with pneumonia being observed as an adverse effect in 1.8% of cases.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a> Among the cases of interstitial pneumonia resulting from the use of immunobiological agents, about 97% are related to TNF-alpha inhibitors. In 89% of cases, patients suffered from psoriatic arthritis, and the pulmonary disease appeared approximately 26 weeks after starting the treatment.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Therefore, the atypical and late presentation of this adverse effect is evident after 5 years of adalimumab use.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In psoriasis with solely cutaneous involvement, adalimumab has shown no significant difference when compared to placebo, regarding adverse effects.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> In countries such as Japan, the dose indicated for the treatment of psoriasis with adalimumab varies between 40 and 80 mg a week, with no significant adverse effects.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> The reported case is noteworthy, as the patient had the cutaneous form of psoriasis, did not use the maximum dose, and nevertheless developed interstitial lung disease due to the use of anti-TNF-alpha.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Ustekinumab (Stelara™), a human IgG1 monoclonal antibody specific for IL-12/23, is also one of the most widely used drugs for the treatment of paradoxical psoriasis cases, which has been shown to be an effective alternative drug.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">This report reinforces the need for special care in relation to the monitoring of immunobiological agent users, whose screening with relevant tests and at the appropriate time is essential for the early diagnosis of potentially severe diseases that may have an asymptomatic presentation.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Financial support</span><p id="par0055" class="elsevierStylePara elsevierViewall">None declared.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Authors’ contributions</span><p id="par0060" class="elsevierStylePara elsevierViewall">Débora Dorneles Cunha de Queiroz Turíbio: Design and planning of the study; collection, analysis, and interpretation of data; drafting and editing of the manuscript; critical review of the literature.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Francisco Clitson Sousa Oliveira: Design and planning of the study; collection, analysis, and interpretation of data; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases.</p><p id="par0070" class="elsevierStylePara elsevierViewall">Sandra Maria Fonseca Barreto: Design and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; critical review of the literature.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Thaís Barros Felippe Jabour: Design and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; critical review of the literature.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Conflicts of interest</span><p id="par0080" class="elsevierStylePara elsevierViewall">None declared.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:9 [ 0 => array:3 [ "identificador" => "xres1550364" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1400151" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Case report" ] 4 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 5 => array:2 [ "identificador" => "sec0020" "titulo" => "Financial support" ] 6 => array:2 [ "identificador" => "sec0025" "titulo" => "Authors’ contributions" ] 7 => array:2 [ "identificador" => "sec0030" "titulo" => "Conflicts of interest" ] 8 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-07-06" "fechaAceptado" => "2020-08-13" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1400151" "palabras" => array:3 [ 0 => "Adalimumab" 1 => "Interstitial lung diseases" 2 => "Psoriasis" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Psoriasis is a chronic inflammatory disease that affects the skin variably, according to genetic and environmental factors. Some patients may benefit from systemic treatment with immunobiological agents, drugs that can be accompanied by several adverse effects. A case of a 58-year-old patient undergoing treatment for psoriasis with adalimumab for five years is reported. Alterations compatible with interstitial pneumonia were detected with important regression after adalimumab discontinuation. This case is relevant due to the scarcity of reports on late pulmonary adverse effect of anti-TNF treatment of psoriasis.</p></span>" ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">How to cite this article: Turíbio DDCQ, Oliveira FCS, Barreto SMF, Jabour TBF. Interstitial lung disease due to anti-TNF use in the treatment of psoriasis. An Bras Dermatol. 2021;96:447–50.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Study conducted at the Department of Medicine, Hospital Universitário Onofre Lopes, Natal, RN, Brazil.</p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 3239 "Ancho" => 3333 "Tamanyo" => 988133 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bilateral pulmonary infiltration characterized by ground-glass opacities and fine reticulation with a basal predominance. Nodular and ground-glass opacities with sparse centrilobular distribution, more evident in the middle lobe.</p>" ] ] 1 => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 3333 "Ancho" => 3333 "Tamanyo" => 1042142 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Sparse reticulonodular opacities in the pulmonary parenchyma bilaterally, more evident in the lower pulmonary fields. In comparison to the previous examination, partial resolution of the opacities was observed.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consenso Brasileiro de Psoríase 2012: Guias de avaliação e tratamento" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Sociedade Brasileira de Dermatologia" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "edicion" => "2. ed" "fecha" => "2012" "editorial" => "SBD" "editorialLocalizacion" => "Rio de Janeiro" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comorbidities in psoriasis patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Kim" 1 => "B. Thrash" 2 => "A. Menter" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.sder.2010.01.002" "Revista" => array:6 [ "tituloSerie" => "Semin Cutan Med Surg." "fecha" => "2010" "volumen" => "29" "paginaInicial" => "10" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20430302" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of adalimumab in the treatment of moderate-to-severe psoriasis: a retrospective study of 100 patients in daily practice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Armesto" 1 => "P. Coto-Segura" 2 => "J. Mayorga" 3 => "A. Illaro" 4 => "J. Santos-Juanes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/09546634.2014.880775" "Revista" => array:6 [ "tituloSerie" => "J Dermatolog Treat." "fecha" => "2015" "volumen" => "26" "paginaInicial" => "49" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24552591" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.V. Cohen" 1 => "B.C. Capell" 2 => "P.A. Kinniry" 3 => "A.L. Epstein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3899/jrheum.100641" "Revista" => array:6 [ "tituloSerie" => "J Rheumatol." "fecha" => "2011" "volumen" => "38" "paginaInicial" => "398" "paginaFinal" => "399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21285183" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Schoe" 1 => "N.E. van der Laan-Baalbergen" 2 => "T.W. Huizinga" 3 => "F.C. Breedveld" 4 => "J.M. van Laar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.21716" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum." "fecha" => "2006" "volumen" => "55" "paginaInicial" => "157" "paginaFinal" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16463430" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Perez-Alvarez" 1 => "M. Perez-de-Lis" 2 => "C. Diaz-Lagares" 3 => "J.M. Pego-Reigosa" 4 => "S. Retamozo" 5 => "A. Bove" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semarthrit.2010.11.002" "Revista" => array:6 [ "tituloSerie" => "Semin Arthritis Rheum." "fecha" => "2011" "volumen" => "41" "paginaInicial" => "256" "paginaFinal" => "264" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21277618" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Schmitt" 1 => "S. Rosumeck" 2 => "G. Thomaschewski" 3 => "B. Sporbeck" 4 => "E. Haufe" 5 => "A. Nast" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bjd.12663" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol." "fecha" => "2014" "volumen" => "170" "paginaInicial" => "274" "paginaFinal" => "303" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24131260" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A. Asahina" 1 => "H. Nakagawa" 2 => "T. Etoh" 3 => "M. Ohtsuki" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1346-8138.2009.00748.x" "Revista" => array:6 [ "tituloSerie" => "J Dermatol." "fecha" => "2010" "volumen" => "37" "paginaInicial" => "299" "paginaFinal" => "310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20507398" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reallife effectiveness of Ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: an IG-IBD study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Pugliese" 1 => "M. Daperno" 2 => "G. Fiorino" 3 => "E. Savarino" 4 => "E. Mosso" 5 => "L. Biancone" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.dld.2019.03.007" "Revista" => array:6 [ "tituloSerie" => "Dig Liver Dis." "fecha" => "2019" "volumen" => "51" "paginaInicial" => "972" "paginaFinal" => "977" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30992173" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Biologicsinduced autoimmune diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Perez-Alvarez" 1 => "M. Perez-de-Lis" 2 => "M. Ramos-Casals" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/BOR.0b013e32835b1366" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Rheumatol." "fecha" => "2013" "volumen" => "25" "paginaInicial" => "56" "paginaFinal" => "64" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23114587" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/03650596/0000009600000004/v4_202107160617/S0365059621001045/v4_202107160617/en/main.assets" "Apartado" => array:4 [ "identificador" => "80638" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case Report" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03650596/0000009600000004/v4_202107160617/S0365059621001045/v4_202107160617/en/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001045?idApp=UINPBA00008Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 15 | 11 | 26 |
| 2024 October | 135 | 90 | 225 |
| 2024 September | 177 | 83 | 260 |
| 2024 August | 187 | 117 | 304 |
| 2024 July | 161 | 101 | 262 |
| 2024 June | 124 | 99 | 223 |
| 2024 May | 99 | 71 | 170 |
| 2024 April | 103 | 87 | 190 |
| 2024 March | 134 | 75 | 209 |
| 2024 February | 116 | 86 | 202 |
| 2024 January | 72 | 58 | 130 |
| 2023 December | 66 | 74 | 140 |
| 2023 November | 83 | 65 | 148 |
| 2023 October | 78 | 79 | 157 |
| 2023 September | 86 | 75 | 161 |
| 2023 August | 89 | 39 | 128 |
| 2023 July | 86 | 29 | 115 |
| 2023 June | 81 | 44 | 125 |
| 2023 May | 73 | 18 | 91 |
| 2023 April | 60 | 9 | 69 |
| 2023 March | 85 | 45 | 130 |
| 2023 February | 68 | 30 | 98 |
| 2023 January | 51 | 48 | 99 |
| 2022 December | 64 | 36 | 100 |
| 2022 November | 74 | 50 | 124 |
| 2022 October | 125 | 49 | 174 |
| 2022 September | 72 | 54 | 126 |
| 2022 August | 38 | 41 | 79 |
| 2022 July | 58 | 54 | 112 |
| 2022 June | 71 | 67 | 138 |
| 2022 May | 49 | 59 | 108 |
| 2022 April | 66 | 49 | 115 |
| 2022 March | 60 | 80 | 140 |
| 2022 February | 54 | 47 | 101 |
| 2022 January | 65 | 81 | 146 |
| 2021 December | 49 | 61 | 110 |
| 2021 November | 57 | 61 | 118 |
| 2021 October | 52 | 91 | 143 |
| 2021 September | 99 | 73 | 172 |
| 2021 August | 110 | 100 | 210 |
| 2021 July | 131 | 81 | 212 |
| 2021 June | 63 | 66 | 129 |
| 2021 May | 11 | 25 | 36 |
Show all
